240 related articles for article (PubMed ID: 24338338)
1. Over-expression of survivin and VEGF in small-cell lung cancer may predict the poorer prognosis.
Chen P; Zhu J; Liu DY; Li HY; Xu N; Hou M
Med Oncol; 2014 Jan; 31(1):775. PubMed ID: 24338338
[TBL] [Abstract][Full Text] [Related]
2. High expression of oncoprotein DEK predicts poor prognosis of small cell lung cancer.
Wang X; Lin L; Ren X; Lin Z; Li Z; Li C; Jin T
Int J Clin Exp Pathol; 2014; 7(8):5016-23. PubMed ID: 25197373
[TBL] [Abstract][Full Text] [Related]
3. [Microvessel density and expressions of survivin and vascular endothelial growth factor in non-small cell lung cancer and their correlations to clinicopathologic features].
Wang L; Li X; Li Y; Xue YW
Ai Zheng; 2005 Jul; 24(7):823-6. PubMed ID: 16004808
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of survivin, cyclin D1, integrin beta1, and VEGF in patients with small adenocarcinoma of stage I lung cancer.
Oshita F; Ito H; Ikehara M; Ohgane N; Hamanaka N; Nakayama H; Saito H; Yamada K; Noda K; Mitsuda A; Kameda Y
Am J Clin Oncol; 2004 Aug; 27(4):425-8. PubMed ID: 15289739
[TBL] [Abstract][Full Text] [Related]
5. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
[TBL] [Abstract][Full Text] [Related]
6. Increased levels of LAPTM4B, VEGF and survivin are correlated with tumor progression and poor prognosis in breast cancer patients.
Li S; Wang L; Meng Y; Chang Y; Xu J; Zhang Q
Oncotarget; 2017 Jun; 8(25):41282-41293. PubMed ID: 28476037
[TBL] [Abstract][Full Text] [Related]
7. [Expression of LncRNA AK09398 and Relationship with Prognosis in Patients with Small Cell Lung Cancer].
Liu B; Liu X; Yang Y; Ge J; Li J
Zhongguo Fei Ai Za Zhi; 2016 Nov; 19(11):754-759. PubMed ID: 27866518
[TBL] [Abstract][Full Text] [Related]
8. Survivin expression impacts prognostically on NSCLC but not SCLC.
Rosato A; Menin C; Boldrin D; Dalla Santa S; Bonaldi L; Scaini MC; Del Bianco P; Zardo D; Fassan M; Cappellesso R; Fassina A
Lung Cancer; 2013 Feb; 79(2):180-6. PubMed ID: 23218791
[TBL] [Abstract][Full Text] [Related]
9. Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters.
Bircan A; Bircan S; Kapucuoglu N; Songur N; Ozturk O; Akkaya A
Pathol Oncol Res; 2010 Dec; 16(4):553-61. PubMed ID: 20349288
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of survivin and VEGF mRNA detection in the cell fraction of the peripheral blood in non-small cell lung cancer patients before and after surgery.
Tang XP; Li J; Yu LC; Chen YC; Shi SB; Zhu LR; Chen P
Lung Cancer; 2013 Aug; 81(2):273-9. PubMed ID: 23756092
[TBL] [Abstract][Full Text] [Related]
11. Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma.
Sun PL; Jin Y; Kim H; Seo AN; Jheon S; Lee CT; Chung JH
Virchows Arch; 2013 Sep; 463(3):427-36. PubMed ID: 23907568
[TBL] [Abstract][Full Text] [Related]
12. Influence of survivin and Bcl-2 expression on the biological behavior of non-small cell lung cancer.
Gao Q; Yang S; Kang MQ
Mol Med Rep; 2012 Jun; 5(6):1409-14. PubMed ID: 22446832
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic significance of OPN and VEGF expression in patients with non-small-cell lung cancer.
Lin Q; Guo L; Lin G; Chen Z; Chen T; Lin J; Zhang B; Gu X
Cancer Epidemiol; 2015 Aug; 39(4):539-44. PubMed ID: 26123318
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of Correlation between TTF-1 and Sensitivity to First-line Chemotherapy and Prognosis in Patients with Small Cell Lung Cancer].
Wang B; Feng N; Shi X; Qi Q; Chi X; Song T; Li H
Zhongguo Fei Ai Za Zhi; 2020 Jul; 23(7):547-553. PubMed ID: 32702788
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of the expression of vascular endothelial growth factors A, B, C, and D and their receptors R1, R2, and R3 in patients with nonsmall cell lung cancer.
Carrillo de Santa Pau E; Arias FC; Caso Peláez E; Muñoz Molina GM; Sánchez Hernández I; Muguruza Trueba I; Moreno Balsalobre R; Sacristán López S; Gómez Pinillos A; del Val Toledo Lobo M
Cancer; 2009 Apr; 115(8):1701-12. PubMed ID: 19197998
[TBL] [Abstract][Full Text] [Related]
16. Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance.
Li XX; Li RJ; Zhao LJ; Liu NB; Wang P
Int J Clin Exp Pathol; 2015; 8(11):14676-84. PubMed ID: 26823791
[TBL] [Abstract][Full Text] [Related]
17. The expression of hypoxia-inducible factor-1α and its clinical significance in lung cancer: a systematic review and meta-analysis.
Ren W; Mi D; Yang K; Cao N; Tian J; Li Z; Ma B
Swiss Med Wkly; 2013; 143():w13855. PubMed ID: 24018850
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of serum IL-17 and VEGF levels in small cell lung cancer.
Lin Q; Xue L; Tian T; Zhang B; Guo L; Lin G; Chen Z; Fan K; Gu X
Int J Biol Markers; 2015 Nov; 30(4):e359-63. PubMed ID: 26165685
[TBL] [Abstract][Full Text] [Related]
19. CHIP involves in non-small cell lung cancer prognosis through VEGF pathway.
Tingting Q; Jiao W; Qingfeng W; Yancheng L; Shijun YU; Zhaoqi W; Dongmei S; ShiLong W
Biomed Pharmacother; 2016 Oct; 83():271-276. PubMed ID: 27392029
[TBL] [Abstract][Full Text] [Related]
20. Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma.
Sun YW; Xuan Q; Shu QA; Wu SS; Chen H; Xiao J; Xiang P; Zhu YP; Wang FL; Zhao ST
Genet Mol Res; 2013 Apr; 12(2):1045-53. PubMed ID: 23613251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
